$599

CGM thoughts: Senseonics vs. Dexcom and Abbott

In light of the recent journal publication of PRECISE II, the US pivotal IDE trial for Senseonics’s Eversense implantable CGM, FENIX has conducted a comparative analysis vs. Abbott Freestyle Libre and Dexcom G5 Mobile, with a particular focus on sensor accuracy across glucose ranges.

This content is for Read Less members only.
Register
Already a member? Log in here